Correll, Christoph U <br/><br/>
Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.  [electronic resource] 

 -  Child and adolescent psychiatric clinics of North America  Jan 2006 
 - 177-206 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1056-4993 
<br/><br/><label>Standard No.: </label>10.1016/j.chc.2005.08.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antipsychotic Agents--adverse effects<br/>Basal Ganglia Diseases--chemically induced<br/>Body Mass Index<br/>Child<br/>Dyslipidemias--chemically induced<br/>Humans<br/>Mental Disorders--drug therapy<br/>Metabolic Syndrome--chemically induced<br/>Prolactin--metabolism<br/>Recognition, Psychology